SciCann Therapeutics has a total of 15 patents globally, out of which 4 have been granted. Of these 15 patents, more than 66% patents are active. The United States of America is where SciCann Therapeutics has filed the maximum number of patents, followed by Europe. Parallelly, United States of America seems to be the main focused R&D centre and also Canada is the origin country of SciCann Therapeutics.
SciCann Therapeutics was founded in 2017. The company specializes in creating cannabis and cannabinoid-based therapeutic products to influence the endocannabinoid system. They focus on discovering and developing innovative technologies in the cannabinoid field for treating life-threatening conditions with unmet needs, facilitating rapid and efficient R&D programs.
Do read about some of the most popular patents of SciCann Therapeutics which have been covered by us in this article and also you can find SciCann Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over SciCann Therapeutics patent portfolio.
How many patents does SciCann Therapeutics have?
SciCann Therapeutics has a total of 15 patents globally. These patents belong to 4 unique patent families. Out of 15 patents, 10 patents are active.
How Many Patents did SciCann Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | SciCann Therapeutics Applications Filed | SciCann Therapeutics Patents Granted |
| 2021 | 1 | 1 |
| 2020 | 3 | 1 |
| 2019 | 5 | 2 |
| 2018 | 6 | – |
How many SciCann Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did SciCann Therapeutics File in Different Countries?
Countries in which SciCann Therapeutics Filed Patents
| Country | Patent |
| United States Of America | 5 |
| Europe | 2 |
| Israel | 1 |
| Canada | 1 |
| Australia | 1 |
| China | 1 |
Where are Research Centers of SciCann Therapeutics Patents Located?
The Research Centers of SciCann Therapeutics Patents is the United States of America.
Best SciCann Therapeutics Patents
WO2019155337A1 is the most popular patent in the SciCann Therapeutics portfolio. It has received 12 citations so far from companies like Add Advanced Drug Delivery Technologies, Cannasmetics, Esserre Pharma.
Below is the list of most cited patents of SciCann Therapeutics:
| Publication Number | Citation Count |
| WO2019155337A1 | 12 |
| WO2019049142A1 | 8 |
| WO2020194237A1 | 6 |
| WO2019159176A1 | 4 |
| US10966953B2 | 1 |
| CN111212638A | 1 |
What Percentage of SciCann Therapeutics US Patent Applications Were Granted?
SciCann Therapeutics (Excluding its subsidiaries) has filed 5 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 3 have been granted leading to a grant rate of 100%.
Below are the key stats of SciCann Therapeutics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for SciCann Therapeutics?
| Law Firm | Total Applications | Success Rate |
| The Roy Gross Law Firm Llc | 5 | 100% |
List of SciCann Therapeutics patents
| SciCann Therapeutics Patents | Title |
| US10966953B2 | Compositions Comprising A Cannabinoid And Spilanthol |
| US10512629B1 | Compositions Comprising A Cannabinoid And Spilanthol |
| US10512614B2 | Compositions Comprising A Cannabinoid And Spilanthol |
| US20220151982A1 | Cannabinoid Compositions And Use Thereof |
| US20210177800A1 | Compositions Comprising A Cannabinoid And Spilanthol |
| EP3946315A4 | Cannabinoid Compositions And Use Thereof |
| EP3678658A4 | Compositions Comprising A Cannabinoid And Spilanthol |
| CA3029528C | Compositions Comprising A Cannabinoid And Spilanthol |
| IL272709A | Compositions Comprising A Cannabinoid And Spilanthol |
| AU2018330807A1 | Compositions Comprising A Cannabinoid And Spilanthol |
| CN111212638A | Compositions Comprising Cannabinoid And Spilanthol |
| WO2020194237A1 | Cannabinoid Compositions And Use Thereof |
| WO2019159176A1 | Compositions And Methods For Treatment Of Neurodegenerative Diseases |
| WO2019155337A1 | Compositions Comprising A Cannabinoid And Punicalagin And Methods Of Use Thereof |
| WO2019049142A1 | Compositions Comprising A Cannabinoid And Spilanthol |
What Technologies are Covered by SciCann Therapeutics?
The chart below distributes patents filed by SciCann Therapeutics